Oncoclínicas do Brasil Serviços Médicos S.A.

BOVESPA:ONCO3 Stock Report

Mkt Cap: R$5.6b

Oncoclínicas do Brasil Serviços Médicos Future Growth

Future criteria checks 4/6

Oncoclínicas do Brasil Serviços Médicos is forecasted to grow earnings and revenue by 36.3% and 14.3% per annum respectively. EPS is expected to grow by 55.7%. Return on equity is forecast to be 16.4% in 3 years.

Key information

36.3%

Earnings growth rate

55.7%

EPS growth rate

Healthcare earnings growth43.4%
Revenue growth rate14.3%
Future return on equity16.4%
Analyst coverage

Good

Last updated14 Sep 2023

Recent future growth updates

Recent updates

Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Sep 11
Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Apr 03
Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Earnings and Revenue Growth Forecasts

BOVESPA:ONCO3 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20257,5266081,0531,9537
12/31/20246,6074697781,5589
12/31/20235,5182001,1691,6907
6/30/20235,033145-25378N/A
3/31/20234,57491-646-346N/A
12/31/20224,08846-576-272N/A
9/30/20223,640-10-740-378N/A
6/30/20223,155105-593-324N/A
3/31/20222,895-67-415-185N/A
12/31/20212,702-47-211-9N/A
9/30/20212,509-203-13827N/A
6/30/20212,354-334-1289N/A
3/31/20212,182-145-17154N/A
12/31/20202,035-158-19186N/A
12/31/20191,690-20-9397N/A
12/31/20181,051-17-296-18N/A
12/31/20177923101135N/A
12/31/2016595-25N/A-21N/A
12/31/2015458-25N/A-3N/A
12/31/2014359-22N/A9N/A
12/31/201326921N/A7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ONCO3's forecast earnings growth (36.3% per year) is above the savings rate (9.7%).

Earnings vs Market: ONCO3's earnings (36.3% per year) are forecast to grow faster than the BR market (12.3% per year).

High Growth Earnings: ONCO3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ONCO3's revenue (14.3% per year) is forecast to grow faster than the BR market (6.4% per year).

High Growth Revenue: ONCO3's revenue (14.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ONCO3's Return on Equity is forecast to be low in 3 years time (16.4%).

Discover growth companies